CorporateAstraZeneca, Bristol Myers in Early Talks for Potential $400 Bn Pharma MergerBY Outlook Business Desk
CorporateAstraZeneca Gets Central Drugs Standard Control Organisation Approval For Durvalumab In Gastric Cancer TreatmentBY PTI